Search results for "ABR"

showing 10 items of 1669 documents

A 15-Year Perspective of the Fabry Outcome Survey

2016

Abstract The Fabry Outcome Survey (FOS) is an international long-term observational registry sponsored by Shire for patients diagnosed with Fabry disease who are receiving or are candidates for therapy with agalsidase alfa (agalα). Established in 2001, FOS provides long-term data on agalα safety/efficacy and collects data on the natural history of Fabry disease, with the aim of improving clinical management. The FOS publications have helped establish prognostic and severity scores, defined the incidence of specific disease variants and implications for clinical management, described clinical manifestations in special populations, confirmed the high prevalence of cardiac morbidity, and demon…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismDisease030204 cardiovascular system & hematologyoutcomesFabry Outcome Survey03 medical and health sciences0302 clinical medicineInternal medicinemedicineGenetics (clinical)lcsh:R5-920agalsidase alfaFabry diseasebusiness.industryIncidence (epidemiology)Therapeutic effectEnzyme replacement therapymedicine.diseaseFabry diseaseNatural historyPediatrics Perinatology and Child HealthPhysical therapyObservational studybusinesslcsh:Medicine (General)Agalsidase alfa030217 neurology & neurosurgeryenzyme replacement therapy
researchProduct

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

2015

Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database, for comparison with data from three published studies. Outcomes evaluated were the annualized rate of change in estimated glomerular filtration rate (eGFR) and left ventricular mass indexed to height (LVMI) as well as time to and ages at a composite morbidity endpoint and at death. FOS data were extracted for 740 treated patients who were followed for a median of ~ 5 years. Compared with no trea…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismUrologyCardiomyopathyRenal functionSE Standard errorLeft ventricular hypertrophyBiochemistryLVH Left ventricular hypertrophyLong-term effectivenessEndocrinologyGeneticsMedicineMDRD Modification of Diet in Renal Diseaselcsh:QH301-705.5Molecular BiologyAgalsidase alfaeGFR Estimated glomerular filtration rateFabry diseaselcsh:R5-920CI Confidence intervalbusiness.industryEnzyme replacement therapymedicine.diseaseEgfr Estimated glomerular filtration rateFabry diseaseSurgeryARB Angiotensin receptor blockerSEM Standard error of the meanStandard errorlcsh:Biology (General)SI:TherapyEnzyme replacement therapyCohortFOS Fabry Outcome SurveyLVMI Left ventricular mass indexed to heightlcsh:Medicine (General)businessACEI Angiotensin-converting enzyme inhibitorAgalsidase alfaERT Enzyme replacement therapyMolecular Genetics and Metabolism Reports
researchProduct

Measuring patient experiences in fabry disease: validation of the Fabry Outcome Survey (FOS) paediatric health and pain questionnaire

2011

medicine.medical_specialtyEndocrinologybusiness.industryEndocrinology Diabetes and MetabolismGeneticsPhysical therapymedicinebusinessmedicine.diseaseMolecular BiologyBiochemistryOutcome (game theory)Fabry diseaseMolecular Genetics and Metabolism
researchProduct

Design and fabrication of an ultra-flexible electrode system for invasive continuous monitoring during surgery

2009

This paper introduces the development, design and characterization of a tube with electrodes for stimulation and recording. This tube can be used as an operative monitoring system for thyroid surgery. In such surgeries damaging of the neural tissue can result in permanently malfunction. Continuous nerve monitoring can reduce significantly this risk.

medicine.medical_specialtyFabricationComputer sciencefungiNeural stimulationContinuous monitoringElectrodemedicinefood and beveragesTube (fluid conveyance)Monitoring systemSurgery
researchProduct

Effects of dietary dehydrated lemon peel on some biochemical markers related to general metabolism, welfare and stress in gilthead seabream (Sparus a…

2019

Dehydrated lemon peel (DLP) at two levels (1.5% and 3%) was included for 30 days in the diet of gilthead seabream (Sparus aurata L.) and after 15 and 30 days the serum and skin mucus of fish were analysed. In serum, both experimental diets led to an initial decrease in glucose and lactate after which the levels became comparable to the control. Dietary DLP modulated the activity of transaminases, alanine aminotransferase and aspartate aminotransferase. The total antioxidant status showed a progressive increase in relation to levels of inclusion of DLP and time of administration (p '.05). In skin mucus, some biomolecular markers related to general stress, oxidative stress and apoptosis exhib…

medicine.medical_specialtyGilthead Seabreamantioxidantdehydrated lemon peelAquatic ScienceBiologymedicine.disease_causegilthead seabream (Sparus aurata)antioxidants dehydrated lemon peel gilthead seabream (Sparus aurata) metabolism welfare03 medical and health sciencesSettore AGR/20 - ZoocoltureInternal medicinemedicineSettore BIO/06 - Anatomia Comparata E CitologiaAlanine aminotransferaseBiochemical markers030304 developmental biology0303 health sciencesLemon peel04 agricultural and veterinary sciencesMetabolismMucuswelfareEndocrinologyApoptosis040102 fisheries0401 agriculture forestry and fisheriesmetabolismOxidative stressAquaculture Research
researchProduct

Downregulation of alpha-galactosidase A upregulates CD77: functional impact for Fabry nephropathy.

2009

Anderson-Fabry disease, an inherited deficiency in the lysosomal enzyme alpha-galactosidase A, is characterized by the progressive accumulation of globotriaosylceramide (Gb3), also known as CD77. We sought to clarify the pathogenesis of Fabry disease by establishing a cell model of this disorder. The expression of alpha-galactosidase A was transiently silenced by RNA interference in HK2 and primary human renal epithelial cells and stably silenced in HK2 cells by retroviral transfection with small hairpin RNA. All of the silenced cells had histological similarities to cells of patients with Fabry disease. The cells had reduced viability, significant accumulation of intracellular Gb3, and a m…

medicine.medical_specialtyGlobotriaosylceramideGb3Cell LineSmall hairpin RNAchemistry.chemical_compoundRNA interferenceDownregulation and upregulationInternal medicineMedicineGene silencingHumansGene SilencingRNA Small InterferingAnderson–Fabry diseaseGlobosidesbusiness.industryTrihexosylceramidesEpithelial CellsTransfectionEnzyme replacement therapymedicine.diseaseFabry diseaseα-galactosidaseEndocrinologychemistryGene Expression RegulationNephrologyCell culturealpha-GalactosidaseCancer researchFabry DiseaseCD77businessenzyme replacement therapyKidney international
researchProduct

Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data

2007

Progressive deposition of globotriaosylceramide results in severe complications involving the kidney, heart and brain in both hemizygous male and heterozygous female patients with Fabry disease. Analysis of renal data from FOS - the Fabry Outcome Survey - suggests that enzyme replacement therapy with agalsidase alfa can significantly improve renal function in patients with Fabry disease, at least in those with a mild decrease in glomerular filtration rate, and may also be able to slow down the natural decline in renal function in patients with a moderate reduction in glomerular filtration rate. Conclusion: Initial results from the large cohort of patients within FOS indicate that treatment …

medicine.medical_specialtyGlobotriaosylceramideUrologyRenal functionchemistry.chemical_compoundInternal medicinemedicineHumansIn patientBeneficial effectsKidneybusiness.industryGeneral MedicineEnzyme replacement therapymedicine.diseaseFabry diseaseRecombinant ProteinsIsoenzymesEndocrinologymedicine.anatomical_structurechemistryalpha-GalactosidasePediatrics Perinatology and Child HealthFabry DiseasebusinessAgalsidase alfaGlomerular Filtration RateActa Paediatrica
researchProduct

Comment: Why are females with Fabry disease affected?

2019

medicine.medical_specialtyHunter Syndromebusiness.industryHunter syndromemedicine.diseaseLysosomal Storage DisorderFabry diseaseEndocrinologyEndocrinologyInternal medicineGeneticsmedicineFabry DiseaseX-inactivationX-linked DisorderbusinessMolecular BiologyLetter to the Editor
researchProduct

Differential expression of two glucocorticoid receptors in seabass (teleost fish) head kidney after exogeneous cortisol inoculation

2009

Stressful conditions include a prompt release of corticosteroid hormones which can mediate gene expression through glucocorticoid receptors (GR). Since two seabass (Dicentrarchus labrax) GRs have been cloned and sequenced from peritoneal cavity cells (DlGR1) and liver (DlGR2), a comparative amino acid sequence analysis that included Haplochromis burtoni HbGRs, was carried out and homologies disclosed. The DlGR1 and DlGR2 deduced aminoacid sequences showed 61% identity (I) and 70% similarity (S). Moreover, DlGR2 was similar to HbGR2b (69% I, 73% S), and the DlGR1 to HbGR1 (72% I, 78% S). In addition, we examined the expression of the DlGRs after exogeneous cortisol inoculation into the perit…

medicine.medical_specialtyHydrocortisonePhysiologySettore BIO/05 - ZoologiaGlucocorticoid receptorKidneyBiochemistryCortisolPeritoneal cavityGlucocorticoid receptorReceptors GlucocorticoidInternal medicineGene expressionmedicineAnimalsDicentrarchus labraxSea bassMolecular BiologyDicentrarchus labrax; Cortisol; Glucocorticoid receptor; Real-time PCRHead KidneyKidneybiologyReverse Transcriptase Polymerase Chain ReactionGene Expression Profilingbiology.organism_classificationmedicine.anatomical_structureEndocrinologyGene Expression RegulationHormone receptorDicentrarchusBassReal-time PCR
researchProduct

Niederfeld MR-Arthrographie der Schulter: Erste Ergebnisse mit einem offenen 0,2 T MR-System

1998

PURPOSE To assess the practicability and image quality of doing MR arthrography of the shoulder using a 0.2T system. PATIENTS AND METHOD 60 patients (24 with chronic instability, 36 with impingement syndrome) were examined in an open 0.2T MR apparatus (Magnetom Open, Siemens). After the intra-articular injections of 15-20 ml of a 2 mmol Gd-DTPA solution, coronary STIR, T1-weighted, sagittal and axial T2*-weighted FLASH 2D sequences were performed. 21 patients subsequently underwent surgery. RESULTS Image quality of the T1- and T2*-weighted FLASH 2D sequences was regarded as good or adequate and movement artifacts were minor or moderate. STIR sequences were statistically significantly worse …

medicine.medical_specialtyLabrummedicine.diagnostic_testbusiness.industryImage qualityImpingement syndromeMagnetic resonance imagingmedicine.diseaseSagittal planeSurgerymedicine.anatomical_structuremedicineRotator cuff ruptureRadiology Nuclear Medicine and imagingShoulder jointRotator cuffNuclear medicinebusinessRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct